Miplyffa (Arimoclomol)

Miplyffa (arimoclomol) is used for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adult and pediatric patients aged 2 years and older.

Recommended Dosage: The recommended oral dosage of Arimoclomol, together with miglustat, for patients with an actual body weight of 8-15 kg is 47 mg three times daily, > 15-30 kg is 62 mg three times daily, > 30-55 kg is 93 mg three times daily, and > 55 kg is 124 mg three times daily. Administer dosage with or without food. Swallow the capsules whole.
In case a dose is missed, the patient should skip the missed dose and resume taking the prescribed dose at the next scheduled time.

Arimoclomol may cause critical hypersensitivity reactions, including swelling, rash, or difficulty breathing. Stop treatment promptly if symptoms arise. Individuals with known hypersensitivity to arimoclomol or its components should not use this medication. Seek immediate medical attention in case reactions occur.
Treatment with Miplyffa 47 mg/62 mg/93 mg/124 mg may harm an unborn baby. Women of childbearing age should use appropriate contraception during treatment and for a certain period after the final dose. Pregnant women should not use this medicine unless necessary.
This therapeutic drug may increase the levels of serum creatinine, which generally does not reflect impaired kidney function. Regularly monitor renal parameters to ensure safety during treatment, mainly in those with pre-existing or any known kidney conditions.
The use of Arimoclomol is not recommended during breastfeeding because of the potential risk to the nursing infant. Nursing mothers should consult their doctor to weigh the benefits of treatment against potential harm and use available alternative feeding options if necessary.

What documents are required to import MIPLYFFA to India?

MIPLYFFA (arimoclomol) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is MIPLYFFA available in India?

MIPLYFFA (arimoclomol capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Miplyffa in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

MIPLYFFA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of MIPLYFFA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Miplyffa capsules price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source MIPLYFFA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Miplyffa®?

Arimoclomol is a Generic Name for the trade name drug Miplyffa®.

What is the Manufacturer's Name of Miplyffa®?

Miplyffa® is manufactured by Zevra Therapeutics, Inc.

Is Miplyffa® approved by the FDA?

Yes, Miplyffa® is approved by the FDA. Date of first approval: September 20, 2024.

What is the dosage and form of Miplyffa® supplied?

Miplyffa is supplied in capsules: 47 mg, 62 mg, 93 mg and 124 mg of arimoclomol for oral use.

What are the most common side effects of Miplyffa®?

The most common side effects of Miplyffa® are decreased weight, upper respiratory tract infection, and diarrhea.

How much does Miplyffa® Capsules cost in India?

Prices of Miplyffa capsules may fluctuate over time because of market dynamics and regulatory changes. To know the most recent details on Miplyffa 47 mg/62 mg/93 mg/124 mg capsules cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Miplyffa® be available in SAARC countries?

Apart from Gulf countries, Miplyffa® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Miplyffa® Capsules in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Miplyffa® Capsuless online in India?

Yes, one can buy Miplyffa online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Miplyffa® 47 mg/62 mg/93 mg/124 mg capsules through legal channels.

What are the storage conditions of Miplyffa® Capsules?

Store the capsules at 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F). Store it in original container. Protect the medicine from light.